New cough combo drug tested in healthy people for first time
NCT ID NCT07161180
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early-phase trial is testing a new combination drug called PBK_M2301, which contains two ingredients: levodropropizine (a cough suppressant) and Pelargonium sidoides extract (a herbal remedy). The study involves 32 healthy adults aged 19 to 64. Each person will take the combination drug and the two ingredients separately at different times, with a week break in between. The goal is to measure how the drug moves through the body and check for any safety issues.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PBK_M2301 (a tablet combining levodropropizine and Pelargonium sidoides extract)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H+ Yangji Hospital
RECRUITINGSeoul, Seoul, 08799, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults